Aspirin & diabetes
This article was originally published in The Tan Sheet
Executive Summary
Aspirin 6 g/day to 8 g/day reduces high blood levels of glucose, insulin and triglycerides associated with insulin resistance in rodents, Minsheng Yuan, MD/PhD, Harvard Medical School, et al., report in Aug. 31 Science. Although dose is toxic compared with therapeutic 650 mg, reversal of insulin resistance via salicylate anti-inflammatory activity points to inflammatory etiology of condition and resulting type II diabetes, researchers note
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning